MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Discover the role of genetic testing in diagnosing Craniofacial-Skeletal-Dermatologic Dysplasia, including whole exome sequencing, targeted gene panels, and prenatal testing.
Prominent forehead, bowed legs, short stature and fracture risk mark craniotubular dysplasia, Ikegawa type, a rare bone disorder with no gene yet identified.
Progressive sensorineural hearing loss that begins in childhood or early adulthood, passed on by one affected parent, and linked to WFS1, GSDME and DIAPH1.
In children with short stature and low IGF-I, the causes considered are GH neurosecretory dysfunction, GH insensitivity and genetic conditions such as ADCL3.
When cells cannot process vitamin B12, homocysteine and methylmalonic acid build up, bringing developmental delay, neurological problems and blood abnormalities.
Low D2 receptor density in the striatum has been tied to drug-seeking behavior, obesity and diabetes risk, and is assessed with PET or SPECT imaging or gene tests.
Explore Dysostosis Multiplex, Ain-Naz Type, its diagnosis, and the role of genetic testing in managing this rare disorder. Discover emerging treatment options.
Discover the importance of genetic testing in diagnosing and managing EGFR-related lung cancer, guiding personalized treatment strategies, and improving patient outcomes.